Profil
Gonzalo de Miquel is currently a Member-Supervisory Board at Ventaleon GmbH since 2017.
Previously, he worked as Director-Global Clinical Development at Almirall SA, Independent Director at ALK-Abello A, and Vice President-Clinical Development at AstraZeneca PLC.
He also served as Chief Medical Officer & Executive VP-Development at Vectura Group Ltd. from 2017 to 2020.
Anciens postes connus de Gonzalo de Miquel
| Sociétés | Poste | Fin |
|---|---|---|
| VECTURA GROUP | Directeur Technique/Scientifique/R&D | 01/03/2020 |
| ALK-ABELLÓ A/S | Directeur/Membre du Conseil | - |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Directeur/Membre du Conseil | - |
| ALMIRALL, S.A. | Corporate Officer/Principal | - |
| ASTRAZENECA PLC | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
AstraZeneca PLC
AstraZeneca PLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Vectura Group Ltd.
Vectura Group Ltd. Pharmaceuticals: MajorHealth Technology Develops and manufactures inhalation drugs and medical devices | Health Technology |
Almirall SA
Almirall SA Pharmaceuticals: MajorHealth Technology Engages in the development, manufacture and sale of pharmaceuticals | Health Technology |
ALK-Abello A/S
ALK-Abello A/S Pharmaceuticals: MajorHealth Technology Develops and produces, markets products for diagnosing, treating allergies, allergic asthma & acute anaphylactic reactions | Health Technology |
Ventaleon GmbH
Ventaleon GmbH Pharmaceuticals: OtherHealth Technology Engages in the research, development, manufacture, and distribution of antiviral substances and treatments taken by inhalation | Health Technology |
















